Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4638488
Max Phase: Preclinical
Molecular Formula: C14H11NO5
Molecular Weight: 273.24
Molecule Type: Unknown
Associated Items:
ID: ALA4638488
Max Phase: Preclinical
Molecular Formula: C14H11NO5
Molecular Weight: 273.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)c1cccc(COc2ccc([N+](=O)[O-])cc2)c1
Standard InChI: InChI=1S/C14H11NO5/c16-14(17)11-3-1-2-10(8-11)9-20-13-6-4-12(5-7-13)15(18)19/h1-8H,9H2,(H,16,17)
Standard InChI Key: DWVGGEQDFZYPQD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 273.24 | Molecular Weight (Monoisotopic): 273.0637 | AlogP: 2.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 89.67 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.02 | CX Basic pKa: | CX LogP: 3.14 | CX LogD: -0.01 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -1.00 |
1. Kronenberger T, Ferreira GM, de Souza ADF, da Silva Santos S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise-Filho R.. (2020) Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors., 28 (15): [PMID:32631571] [10.1016/j.bmc.2020.115600] |
Source(1):